Racial disparities in the receipt of therapies for cancer, hypertension, and diabetes, and in mortality in a large population-based cohort of older men with prostate cancer

Datos Bibliográficos

ID6423103
AutoresZhuoyun Li (0000-0002-0706-1784, The University of Texas Health Science Center at Houston), Xianglin L Du (0000-0003-0119-5252, The University of Texas Health Science Center at Houston, autor de correspondencia)
Año2025
Volumen30
Número6
Páginas699-717
Fecha de publicación2025-07-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaEthnicity and Health (JOURNAL)
Identificadores de la revistaISSN: 1355-7858 • E-ISSN: 1465-3419
EditorialTaylor & Francis (PUBLISHER • GB)
DOI10.1080/13557858.2025.2525791
PMID40598758
OpenAlexW4411893914
IdiomaEN
Referencias citadas38

There were substantial racial disparities in the receipt of cancer treatments and antihypertension and antidiabetic drugs. Non-Hispanic Black patients with prostate cancer still had a considerably higher risk of all-cause and cancer-specific mortality than non-Hispanic Whites after accounting for demographic, therapy, and tumor factors

Cancer · Cohort · Diabetes mellitus · Environmental health · Population · Prostate cancer · Receipt · Colorectal Cancer Screening and Detection · Medicine · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research · Endocrinology · Internal Medicine · Oncology